Cronos (CRON) Return on Capital Employed (2020 - 2026)
Cronos (CRON) recorded quarterly Return on Capital Employed of 1.33% in Q1 2026, up 13.07% quarter-over-quarter from 1.53% in Q4 2025, and up 441.0% on a YoY basis from 0.25% in Q1 2025.
Cronos (CRON) Return on Capital Employed (2020 - 2026) Analysis & Trends
Cronos' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 1.33% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 441.0% year-over-year to 1.33%; the TTM figure through Mar 2026 stood at 1.33% (up 441.0% YoY), while the FY2025 annual figure was 1.53%, up 540.0% from the prior year.
- Return on Capital Employed was 1.33% for Q1 2026 at Cronos, up from 1.53% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1.39% in Q3 2022 to a low of 21.04% in Q1 2022.
- Historically, Return on Capital Employed has averaged 6.3% across 5 years, with a median of 7.02% in 2024.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed soared 3183 bps in 2022, then plunged 938 bps in 2023.
- A 5-year view of Return on Capital Employed shows it stood at 9.49% in 2022, then advanced by 19 bps to 7.68% in 2023, then gained by 11 bps to 6.8% in 2024, then surged by 78 bps to 1.53% in 2025, then grew by 13 bps to 1.33% in 2026.
- The last three Return on Capital Employed figures came in at 1.33% (Q1 2026), 1.53% (Q4 2025), and 1.87% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | -1.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33% |
| Dec 31, 2025 | -1.53% |
| Sep 30, 2025 | -1.87% |
| Jun 30, 2025 | -4.83% |
| Mar 31, 2025 | -5.74% |
| Dec 31, 2024 | -6.80% |
| Sep 30, 2024 | -7.91% |
| Jun 30, 2024 | -7.02% |
| Mar 31, 2024 | -7.33% |
| Dec 31, 2023 | -7.68% |
| Sep 30, 2023 | -7.99% |
| Jun 30, 2023 | -8.43% |
| Mar 31, 2023 | -8.68% |
| Dec 31, 2022 | -9.49% |
| Sep 30, 2022 | 1.39% |
| Jun 30, 2022 | -0.90% |
| Mar 31, 2022 | -21.04% |
| Dec 31, 2021 | -20.09% |
| Sep 30, 2021 | -30.44% |
| Jun 30, 2021 | -28.62% |